nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolazamide—ABCC8—penis—prostate cancer	0.0672	0.48	CbGeAlD
Tolazamide—KCNJ1—renal system—prostate cancer	0.0196	0.14	CbGeAlD
Tolazamide—ABCC8—prostate gland—prostate cancer	0.0161	0.115	CbGeAlD
Tolazamide—ABCC8—seminal vesicle—prostate cancer	0.0136	0.097	CbGeAlD
Tolazamide—ABCC8—renal system—prostate cancer	0.0109	0.0782	CbGeAlD
Tolazamide—ABCC8—testis—prostate cancer	0.00707	0.0505	CbGeAlD
Tolazamide—KCNJ11—lymph node—prostate cancer	0.00557	0.0398	CbGeAlD
Tolazamide—Gliclazide—VEGFA—prostate cancer	0.00442	0.263	CrCbGaD
Tolazamide—Tolbutamide—CYP2C18—prostate cancer	0.00362	0.216	CrCbGaD
Tolazamide—Asthenia—Flutamide—prostate cancer	0.00242	0.00368	CcSEcCtD
Tolazamide—Dizziness—Estrone—prostate cancer	0.00241	0.00367	CcSEcCtD
Tolazamide—Rash—Estramustine—prostate cancer	0.00241	0.00366	CcSEcCtD
Tolazamide—Urticaria—Degarelix—prostate cancer	0.0024	0.00366	CcSEcCtD
Tolazamide—Pruritus—Nilutamide—prostate cancer	0.0024	0.00365	CcSEcCtD
Tolazamide—Thrombocytopenia—Bicalutamide—prostate cancer	0.00239	0.00364	CcSEcCtD
Tolazamide—Headache—Estramustine—prostate cancer	0.00239	0.00364	CcSEcCtD
Tolazamide—Abdominal distension—Estradiol—prostate cancer	0.00239	0.00363	CcSEcCtD
Tolazamide—Pruritus—Flutamide—prostate cancer	0.00239	0.00363	CcSEcCtD
Tolazamide—Ill-defined disorder—Ethinyl Estradiol—prostate cancer	0.00235	0.00358	CcSEcCtD
Tolazamide—Feeling abnormal—Cabazitaxel—prostate cancer	0.00235	0.00358	CcSEcCtD
Tolazamide—Rash—Abiraterone—prostate cancer	0.00234	0.00356	CcSEcCtD
Tolazamide—Rash—Estrone—prostate cancer	0.0023	0.0035	CcSEcCtD
Tolazamide—Headache—Estrone—prostate cancer	0.00228	0.00348	CcSEcCtD
Tolazamide—Malaise—Ethinyl Estradiol—prostate cancer	0.00228	0.00348	CcSEcCtD
Tolazamide—Asthenia—Estradiol valerate/Dienogest—prostate cancer	0.00228	0.00348	CcSEcCtD
Tolazamide—Nausea—Estramustine—prostate cancer	0.00227	0.00345	CcSEcCtD
Tolazamide—Pruritus—Estradiol valerate/Dienogest—prostate cancer	0.00225	0.00343	CcSEcCtD
Tolazamide—Dizziness—Nilutamide—prostate cancer	0.00224	0.00341	CcSEcCtD
Tolazamide—Dizziness—Flutamide—prostate cancer	0.00223	0.00339	CcSEcCtD
Tolazamide—Asthenia—Degarelix—prostate cancer	0.00217	0.0033	CcSEcCtD
Tolazamide—Nausea—Estrone—prostate cancer	0.00217	0.0033	CcSEcCtD
Tolazamide—Photosensitivity reaction—Estradiol—prostate cancer	0.00216	0.00329	CcSEcCtD
Tolazamide—Dyspepsia—Bicalutamide—prostate cancer	0.00215	0.00328	CcSEcCtD
Tolazamide—Pruritus—Degarelix—prostate cancer	0.00214	0.00326	CcSEcCtD
Tolazamide—Gliclazide—CYP2C19—prostate cancer	0.00214	0.128	CrCbGaD
Tolazamide—Rash—Nilutamide—prostate cancer	0.00214	0.00325	CcSEcCtD
Tolazamide—Discomfort—Ethinyl Estradiol—prostate cancer	0.00213	0.00324	CcSEcCtD
Tolazamide—Rash—Flutamide—prostate cancer	0.00213	0.00324	CcSEcCtD
Tolazamide—Headache—Nilutamide—prostate cancer	0.00212	0.00323	CcSEcCtD
Tolazamide—Headache—Flutamide—prostate cancer	0.00211	0.00322	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Bicalutamide—prostate cancer	0.00211	0.00321	CcSEcCtD
Tolazamide—Fatigue—Bicalutamide—prostate cancer	0.00211	0.00321	CcSEcCtD
Tolazamide—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.0021	0.0032	CcSEcCtD
Tolazamide—Pancytopenia—Mitoxantrone—prostate cancer	0.0021	0.00319	CcSEcCtD
Tolazamide—Erythema—Goserelin—prostate cancer	0.00208	0.00317	CcSEcCtD
Tolazamide—Erythema—Conjugated Estrogens—prostate cancer	0.00206	0.00314	CcSEcCtD
Tolazamide—Asthenia—Cabazitaxel—prostate cancer	0.00204	0.00311	CcSEcCtD
Tolazamide—Feeling abnormal—Bicalutamide—prostate cancer	0.00201	0.00307	CcSEcCtD
Tolazamide—Nausea—Nilutamide—prostate cancer	0.00201	0.00306	CcSEcCtD
Tolazamide—Rash—Estradiol valerate/Dienogest—prostate cancer	0.00201	0.00305	CcSEcCtD
Tolazamide—Nausea—Flutamide—prostate cancer	0.002	0.00305	CcSEcCtD
Tolazamide—Dizziness—Degarelix—prostate cancer	0.002	0.00305	CcSEcCtD
Tolazamide—Headache—Estradiol valerate/Dienogest—prostate cancer	0.00199	0.00303	CcSEcCtD
Tolazamide—Urticaria—Bicalutamide—prostate cancer	0.00194	0.00296	CcSEcCtD
Tolazamide—Ill-defined disorder—Goserelin—prostate cancer	0.00193	0.00294	CcSEcCtD
Tolazamide—Rash—Degarelix—prostate cancer	0.00191	0.0029	CcSEcCtD
Tolazamide—Headache—Degarelix—prostate cancer	0.0019	0.00289	CcSEcCtD
Tolazamide—Haemolytic anaemia—Capecitabine—prostate cancer	0.0019	0.00288	CcSEcCtD
Tolazamide—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.00189	0.00288	CcSEcCtD
Tolazamide—Dizziness—Cabazitaxel—prostate cancer	0.00188	0.00287	CcSEcCtD
Tolazamide—Malaise—Goserelin—prostate cancer	0.00188	0.00286	CcSEcCtD
Tolazamide—Jaundice cholestatic—Epirubicin—prostate cancer	0.00187	0.00284	CcSEcCtD
Tolazamide—Leukopenia—Goserelin—prostate cancer	0.00187	0.00284	CcSEcCtD
Tolazamide—Vertigo—Conjugated Estrogens—prostate cancer	0.00185	0.00282	CcSEcCtD
Tolazamide—Agranulocytosis—Mitoxantrone—prostate cancer	0.00184	0.0028	CcSEcCtD
Tolazamide—Nausea—Degarelix—prostate cancer	0.0018	0.00274	CcSEcCtD
Tolazamide—Headache—Cabazitaxel—prostate cancer	0.00179	0.00272	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Ethinyl Estradiol—prostate cancer	0.00178	0.00272	CcSEcCtD
Tolazamide—Fatigue—Ethinyl Estradiol—prostate cancer	0.00178	0.00271	CcSEcCtD
Tolazamide—Hyponatraemia—Docetaxel—prostate cancer	0.00177	0.0027	CcSEcCtD
Tolazamide—Asthenia—Bicalutamide—prostate cancer	0.00175	0.00267	CcSEcCtD
Tolazamide—Discomfort—Goserelin—prostate cancer	0.00175	0.00267	CcSEcCtD
Tolazamide—Pancytopenia—Etoposide—prostate cancer	0.00175	0.00266	CcSEcCtD
Tolazamide—Pruritus—Bicalutamide—prostate cancer	0.00173	0.00263	CcSEcCtD
Tolazamide—Jaundice cholestatic—Doxorubicin—prostate cancer	0.00173	0.00263	CcSEcCtD
Tolazamide—Hyponatraemia—Capecitabine—prostate cancer	0.00172	0.00261	CcSEcCtD
Tolazamide—Feeling abnormal—Ethinyl Estradiol—prostate cancer	0.0017	0.00259	CcSEcCtD
Tolazamide—Nausea—Cabazitaxel—prostate cancer	0.00169	0.00258	CcSEcCtD
Tolazamide—Thrombocytopenia—Goserelin—prostate cancer	0.00167	0.00254	CcSEcCtD
Tolazamide—Chlorpropamide—CYP2C19—prostate cancer	0.00166	0.0993	CrCbGaD
Tolazamide—Erythema—Estradiol—prostate cancer	0.00165	0.00252	CcSEcCtD
Tolazamide—Urticaria—Ethinyl Estradiol—prostate cancer	0.00164	0.0025	CcSEcCtD
Tolazamide—Tolbutamide—CYP2C19—prostate cancer	0.00162	0.0968	CrCbGaD
Tolazamide—Dizziness—Bicalutamide—prostate cancer	0.00162	0.00246	CcSEcCtD
Tolazamide—Rash—Bicalutamide—prostate cancer	0.00154	0.00235	CcSEcCtD
Tolazamide—Aplastic anaemia—Epirubicin—prostate cancer	0.00154	0.00235	CcSEcCtD
Tolazamide—Erythema—Mitoxantrone—prostate cancer	0.00154	0.00234	CcSEcCtD
Tolazamide—Ill-defined disorder—Estradiol—prostate cancer	0.00153	0.00233	CcSEcCtD
Tolazamide—Headache—Bicalutamide—prostate cancer	0.00153	0.00233	CcSEcCtD
Tolazamide—Agranulocytosis—Etoposide—prostate cancer	0.00153	0.00233	CcSEcCtD
Tolazamide—Dyspepsia—Goserelin—prostate cancer	0.0015	0.00228	CcSEcCtD
Tolazamide—Malaise—Estradiol—prostate cancer	0.00149	0.00227	CcSEcCtD
Tolazamide—Abdominal distension—Capecitabine—prostate cancer	0.00149	0.00227	CcSEcCtD
Tolazamide—Vertigo—Estradiol—prostate cancer	0.00148	0.00226	CcSEcCtD
Tolazamide—Dyspepsia—Conjugated Estrogens—prostate cancer	0.00148	0.00226	CcSEcCtD
Tolazamide—Asthenia—Ethinyl Estradiol—prostate cancer	0.00148	0.00226	CcSEcCtD
Tolazamide—Fatigue—Goserelin—prostate cancer	0.00147	0.00223	CcSEcCtD
Tolazamide—Glipizide—CYP3A4—prostate cancer	0.00146	0.0873	CrCbGaD
Tolazamide—Pruritus—Ethinyl Estradiol—prostate cancer	0.00146	0.00223	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Conjugated Estrogens—prostate cancer	0.00145	0.00221	CcSEcCtD
Tolazamide—Fatigue—Conjugated Estrogens—prostate cancer	0.00145	0.00221	CcSEcCtD
Tolazamide—Nausea—Bicalutamide—prostate cancer	0.00145	0.00221	CcSEcCtD
Tolazamide—Pancytopenia—Docetaxel—prostate cancer	0.00145	0.00221	CcSEcCtD
Tolazamide—Ill-defined disorder—Mitoxantrone—prostate cancer	0.00143	0.00217	CcSEcCtD
Tolazamide—Aplastic anaemia—Doxorubicin—prostate cancer	0.00143	0.00217	CcSEcCtD
Tolazamide—Pancytopenia—Capecitabine—prostate cancer	0.0014	0.00214	CcSEcCtD
Tolazamide—Feeling abnormal—Goserelin—prostate cancer	0.0014	0.00213	CcSEcCtD
Tolazamide—Discomfort—Estradiol—prostate cancer	0.00139	0.00212	CcSEcCtD
Tolazamide—Malaise—Mitoxantrone—prostate cancer	0.00139	0.00211	CcSEcCtD
Tolazamide—Leukopenia—Mitoxantrone—prostate cancer	0.00138	0.0021	CcSEcCtD
Tolazamide—Dizziness—Ethinyl Estradiol—prostate cancer	0.00137	0.00208	CcSEcCtD
Tolazamide—Urticaria—Goserelin—prostate cancer	0.00135	0.00206	CcSEcCtD
Tolazamide—Photosensitivity reaction—Capecitabine—prostate cancer	0.00135	0.00205	CcSEcCtD
Tolazamide—Urticaria—Conjugated Estrogens—prostate cancer	0.00134	0.00204	CcSEcCtD
Tolazamide—Abdominal distension—Prednisone—prostate cancer	0.00133	0.00202	CcSEcCtD
Tolazamide—Rash—Ethinyl Estradiol—prostate cancer	0.0013	0.00198	CcSEcCtD
Tolazamide—Discomfort—Mitoxantrone—prostate cancer	0.00129	0.00197	CcSEcCtD
Tolazamide—Headache—Ethinyl Estradiol—prostate cancer	0.00129	0.00197	CcSEcCtD
Tolazamide—Agranulocytosis—Docetaxel—prostate cancer	0.00127	0.00193	CcSEcCtD
Tolazamide—Agranulocytosis—Capecitabine—prostate cancer	0.00123	0.00187	CcSEcCtD
Tolazamide—Thrombocytopenia—Mitoxantrone—prostate cancer	0.00123	0.00187	CcSEcCtD
Tolazamide—Nausea—Ethinyl Estradiol—prostate cancer	0.00123	0.00187	CcSEcCtD
Tolazamide—Hypoglycaemia—Epirubicin—prostate cancer	0.00122	0.00186	CcSEcCtD
Tolazamide—Asthenia—Goserelin—prostate cancer	0.00122	0.00186	CcSEcCtD
Tolazamide—Asthenia—Conjugated Estrogens—prostate cancer	0.00121	0.00184	CcSEcCtD
Tolazamide—Pruritus—Goserelin—prostate cancer	0.0012	0.00183	CcSEcCtD
Tolazamide—Hyponatraemia—Epirubicin—prostate cancer	0.0012	0.00182	CcSEcCtD
Tolazamide—Pruritus—Conjugated Estrogens—prostate cancer	0.00119	0.00181	CcSEcCtD
Tolazamide—Ill-defined disorder—Etoposide—prostate cancer	0.00119	0.00181	CcSEcCtD
Tolazamide—Dyspepsia—Estradiol—prostate cancer	0.00119	0.00181	CcSEcCtD
Tolazamide—KCNJ1—Neuronal System—PRKACB—prostate cancer	0.00117	0.00628	CbGpPWpGaD
Tolazamide—Gastrointestinal disorder—Estradiol—prostate cancer	0.00116	0.00177	CcSEcCtD
Tolazamide—Fatigue—Estradiol—prostate cancer	0.00116	0.00177	CcSEcCtD
Tolazamide—KCNJ11—Regulation of insulin secretion—ITPR1—prostate cancer	0.00116	0.00621	CbGpPWpGaD
Tolazamide—Malaise—Etoposide—prostate cancer	0.00115	0.00176	CcSEcCtD
Tolazamide—Vertigo—Etoposide—prostate cancer	0.00115	0.00175	CcSEcCtD
Tolazamide—Leukopenia—Etoposide—prostate cancer	0.00115	0.00174	CcSEcCtD
Tolazamide—Hypoglycaemia—Doxorubicin—prostate cancer	0.00113	0.00172	CcSEcCtD
Tolazamide—Dizziness—Goserelin—prostate cancer	0.00112	0.00171	CcSEcCtD
Tolazamide—Glyburide—CYP2C19—prostate cancer	0.00112	0.0671	CrCbGaD
Tolazamide—Dizziness—Conjugated Estrogens—prostate cancer	0.00111	0.0017	CcSEcCtD
Tolazamide—Feeling abnormal—Estradiol—prostate cancer	0.00111	0.00169	CcSEcCtD
Tolazamide—Hyponatraemia—Doxorubicin—prostate cancer	0.00111	0.00169	CcSEcCtD
Tolazamide—Dyspepsia—Mitoxantrone—prostate cancer	0.00111	0.00168	CcSEcCtD
Tolazamide—Fatigue—Mitoxantrone—prostate cancer	0.00108	0.00165	CcSEcCtD
Tolazamide—Discomfort—Etoposide—prostate cancer	0.00108	0.00164	CcSEcCtD
Tolazamide—Rash—Goserelin—prostate cancer	0.00107	0.00163	CcSEcCtD
Tolazamide—Urticaria—Estradiol—prostate cancer	0.00107	0.00163	CcSEcCtD
Tolazamide—Headache—Goserelin—prostate cancer	0.00107	0.00162	CcSEcCtD
Tolazamide—Erythema—Docetaxel—prostate cancer	0.00106	0.00162	CcSEcCtD
Tolazamide—Rash—Conjugated Estrogens—prostate cancer	0.00106	0.00162	CcSEcCtD
Tolazamide—Headache—Conjugated Estrogens—prostate cancer	0.00106	0.00161	CcSEcCtD
Tolazamide—Abdominal distension—Epirubicin—prostate cancer	0.00104	0.00158	CcSEcCtD
Tolazamide—Feeling abnormal—Mitoxantrone—prostate cancer	0.00104	0.00158	CcSEcCtD
Tolazamide—Erythema—Capecitabine—prostate cancer	0.00103	0.00157	CcSEcCtD
Tolazamide—Thrombocytopenia—Etoposide—prostate cancer	0.00102	0.00156	CcSEcCtD
Tolazamide—ABCC8—Neuronal System—RRAS—prostate cancer	0.00102	0.00547	CbGpPWpGaD
Tolazamide—Nausea—Goserelin—prostate cancer	0.00101	0.00154	CcSEcCtD
Tolazamide—Nausea—Conjugated Estrogens—prostate cancer	0.001	0.00152	CcSEcCtD
Tolazamide—Urticaria—Mitoxantrone—prostate cancer	0.000998	0.00152	CcSEcCtD
Tolazamide—KCNJ11—Neuronal System—RRAS—prostate cancer	0.000988	0.0053	CbGpPWpGaD
Tolazamide—Pancytopenia—Epirubicin—prostate cancer	0.000978	0.00149	CcSEcCtD
Tolazamide—Asthenia—Estradiol—prostate cancer	0.000967	0.00147	CcSEcCtD
Tolazamide—Abdominal distension—Doxorubicin—prostate cancer	0.00096	0.00146	CcSEcCtD
Tolazamide—Ill-defined disorder—Capecitabine—prostate cancer	0.000956	0.00146	CcSEcCtD
Tolazamide—ABCC8—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.000954	0.00512	CbGpPWpGaD
Tolazamide—Pruritus—Estradiol—prostate cancer	0.000954	0.00145	CcSEcCtD
Tolazamide—Leukopenia—Docetaxel—prostate cancer	0.000953	0.00145	CcSEcCtD
Tolazamide—Photosensitivity reaction—Epirubicin—prostate cancer	0.00094	0.00143	CcSEcCtD
Tolazamide—ABCC8—Integration of energy metabolism—ITPR1—prostate cancer	0.000938	0.00504	CbGpPWpGaD
Tolazamide—Malaise—Capecitabine—prostate cancer	0.000929	0.00141	CcSEcCtD
Tolazamide—Vertigo—Capecitabine—prostate cancer	0.000926	0.00141	CcSEcCtD
Tolazamide—Leukopenia—Capecitabine—prostate cancer	0.000922	0.0014	CcSEcCtD
Tolazamide—Erythema—Prednisone—prostate cancer	0.000918	0.0014	CcSEcCtD
Tolazamide—KCNJ11—Integration of energy metabolism—ITPR1—prostate cancer	0.00091	0.00488	CbGpPWpGaD
Tolazamide—Pancytopenia—Doxorubicin—prostate cancer	0.000905	0.00138	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Etoposide—prostate cancer	0.000902	0.00137	CcSEcCtD
Tolazamide—Asthenia—Mitoxantrone—prostate cancer	0.000901	0.00137	CcSEcCtD
Tolazamide—Fatigue—Etoposide—prostate cancer	0.000901	0.00137	CcSEcCtD
Tolazamide—Dizziness—Estradiol—prostate cancer	0.000892	0.00136	CcSEcCtD
Tolazamide—Photosensitivity reaction—Doxorubicin—prostate cancer	0.00087	0.00132	CcSEcCtD
Tolazamide—Discomfort—Capecitabine—prostate cancer	0.000867	0.00132	CcSEcCtD
Tolazamide—Feeling abnormal—Etoposide—prostate cancer	0.000861	0.00131	CcSEcCtD
Tolazamide—Agranulocytosis—Epirubicin—prostate cancer	0.000857	0.0013	CcSEcCtD
Tolazamide—KCNJ1—Neuronal System—COMT—prostate cancer	0.000852	0.00457	CbGpPWpGaD
Tolazamide—Ill-defined disorder—Prednisone—prostate cancer	0.000851	0.0013	CcSEcCtD
Tolazamide—Thrombocytopenia—Docetaxel—prostate cancer	0.00085	0.00129	CcSEcCtD
Tolazamide—Rash—Estradiol—prostate cancer	0.00085	0.00129	CcSEcCtD
Tolazamide—Headache—Estradiol—prostate cancer	0.000845	0.00129	CcSEcCtD
Tolazamide—Urticaria—Etoposide—prostate cancer	0.00083	0.00126	CcSEcCtD
Tolazamide—Malaise—Prednisone—prostate cancer	0.000828	0.00126	CcSEcCtD
Tolazamide—Vertigo—Prednisone—prostate cancer	0.000825	0.00126	CcSEcCtD
Tolazamide—Thrombocytopenia—Capecitabine—prostate cancer	0.000823	0.00125	CcSEcCtD
Tolazamide—Nausea—Estradiol—prostate cancer	0.000801	0.00122	CcSEcCtD
Tolazamide—Agranulocytosis—Doxorubicin—prostate cancer	0.000793	0.00121	CcSEcCtD
Tolazamide—Rash—Mitoxantrone—prostate cancer	0.000792	0.00121	CcSEcCtD
Tolazamide—Headache—Mitoxantrone—prostate cancer	0.000787	0.0012	CcSEcCtD
Tolazamide—ABCC8—Regulation of insulin secretion—INS—prostate cancer	0.000783	0.0042	CbGpPWpGaD
Tolazamide—ABCC8—Neuronal System—PLCB2—prostate cancer	0.000773	0.00415	CbGpPWpGaD
Tolazamide—Discomfort—Prednisone—prostate cancer	0.000772	0.00118	CcSEcCtD
Tolazamide—Dyspepsia—Docetaxel—prostate cancer	0.000764	0.00116	CcSEcCtD
Tolazamide—KCNJ11—Regulation of insulin secretion—INS—prostate cancer	0.00076	0.00408	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000754	0.00405	CbGpPWpGaD
Tolazamide—Gastrointestinal disorder—Docetaxel—prostate cancer	0.00075	0.00114	CcSEcCtD
Tolazamide—Asthenia—Etoposide—prostate cancer	0.00075	0.00114	CcSEcCtD
Tolazamide—KCNJ11—Neuronal System—PLCB2—prostate cancer	0.000749	0.00402	CbGpPWpGaD
Tolazamide—Fatigue—Docetaxel—prostate cancer	0.000749	0.00114	CcSEcCtD
Tolazamide—Nausea—Mitoxantrone—prostate cancer	0.000746	0.00114	CcSEcCtD
Tolazamide—Dyspepsia—Capecitabine—prostate cancer	0.00074	0.00113	CcSEcCtD
Tolazamide—Pruritus—Etoposide—prostate cancer	0.000739	0.00113	CcSEcCtD
Tolazamide—ABCC8—Neuronal System—SLC22A1—prostate cancer	0.000737	0.00396	CbGpPWpGaD
Tolazamide—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000726	0.00111	CcSEcCtD
Tolazamide—Fatigue—Capecitabine—prostate cancer	0.000725	0.0011	CcSEcCtD
Tolazamide—Erythema—Epirubicin—prostate cancer	0.000718	0.00109	CcSEcCtD
Tolazamide—Feeling abnormal—Docetaxel—prostate cancer	0.000716	0.00109	CcSEcCtD
Tolazamide—Glyburide—CYP3A4—prostate cancer	0.000715	0.0426	CrCbGaD
Tolazamide—KCNJ11—Neuronal System—SLC22A1—prostate cancer	0.000715	0.00384	CbGpPWpGaD
Tolazamide—ABCC8—Neuronal System—GNG5—prostate cancer	0.000701	0.00376	CbGpPWpGaD
Tolazamide—Feeling abnormal—Capecitabine—prostate cancer	0.000693	0.00105	CcSEcCtD
Tolazamide—Dizziness—Etoposide—prostate cancer	0.000691	0.00105	CcSEcCtD
Tolazamide—KCNJ11—Neuronal System—GNG5—prostate cancer	0.00068	0.00365	CbGpPWpGaD
Tolazamide—Urticaria—Capecitabine—prostate cancer	0.000668	0.00102	CcSEcCtD
Tolazamide—Ill-defined disorder—Epirubicin—prostate cancer	0.000666	0.00101	CcSEcCtD
Tolazamide—Erythema—Doxorubicin—prostate cancer	0.000664	0.00101	CcSEcCtD
Tolazamide—Dyspepsia—Prednisone—prostate cancer	0.000659	0.001	CcSEcCtD
Tolazamide—Rash—Etoposide—prostate cancer	0.000659	0.001	CcSEcCtD
Tolazamide—Headache—Etoposide—prostate cancer	0.000655	0.000997	CcSEcCtD
Tolazamide—Malaise—Epirubicin—prostate cancer	0.000647	0.000985	CcSEcCtD
Tolazamide—Fatigue—Prednisone—prostate cancer	0.000646	0.000983	CcSEcCtD
Tolazamide—Vertigo—Epirubicin—prostate cancer	0.000645	0.000982	CcSEcCtD
Tolazamide—Leukopenia—Epirubicin—prostate cancer	0.000642	0.000978	CcSEcCtD
Tolazamide—ABCC8—Neuronal System—ACHE—prostate cancer	0.000625	0.00335	CbGpPWpGaD
Tolazamide—Asthenia—Docetaxel—prostate cancer	0.000623	0.000949	CcSEcCtD
Tolazamide—Nausea—Etoposide—prostate cancer	0.000621	0.000945	CcSEcCtD
Tolazamide—Feeling abnormal—Prednisone—prostate cancer	0.000617	0.00094	CcSEcCtD
Tolazamide—Ill-defined disorder—Doxorubicin—prostate cancer	0.000616	0.000938	CcSEcCtD
Tolazamide—ABCC8—Integration of energy metabolism—INS—prostate cancer	0.000616	0.00331	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.000615	0.0033	CbGpPWpGaD
Tolazamide—Pruritus—Docetaxel—prostate cancer	0.000614	0.000935	CcSEcCtD
Tolazamide—KCNJ11—Neuronal System—ACHE—prostate cancer	0.000606	0.00325	CbGpPWpGaD
Tolazamide—Discomfort—Epirubicin—prostate cancer	0.000604	0.000919	CcSEcCtD
Tolazamide—Asthenia—Capecitabine—prostate cancer	0.000603	0.000918	CcSEcCtD
Tolazamide—ABCC8—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.000599	0.00322	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.000599	0.00322	CbGpPWpGaD
Tolazamide—Malaise—Doxorubicin—prostate cancer	0.000599	0.000912	CcSEcCtD
Tolazamide—ABCC8—Neuronal System—PRKACB—prostate cancer	0.000598	0.00321	CbGpPWpGaD
Tolazamide—KCNJ11—Integration of energy metabolism—INS—prostate cancer	0.000597	0.00321	CbGpPWpGaD
Tolazamide—Vertigo—Doxorubicin—prostate cancer	0.000597	0.000908	CcSEcCtD
Tolazamide—Urticaria—Prednisone—prostate cancer	0.000595	0.000906	CcSEcCtD
Tolazamide—Pruritus—Capecitabine—prostate cancer	0.000595	0.000906	CcSEcCtD
Tolazamide—Leukopenia—Doxorubicin—prostate cancer	0.000594	0.000905	CcSEcCtD
Tolazamide—KCNJ11—Neuronal System—PRKACB—prostate cancer	0.00058	0.00311	CbGpPWpGaD
Tolazamide—Dizziness—Docetaxel—prostate cancer	0.000574	0.000874	CcSEcCtD
Tolazamide—Thrombocytopenia—Epirubicin—prostate cancer	0.000574	0.000873	CcSEcCtD
Tolazamide—Discomfort—Doxorubicin—prostate cancer	0.000559	0.00085	CcSEcCtD
Tolazamide—Dizziness—Capecitabine—prostate cancer	0.000556	0.000846	CcSEcCtD
Tolazamide—ABCC8—Metabolism—HAO1—prostate cancer	0.000548	0.00294	CbGpPWpGaD
Tolazamide—Rash—Docetaxel—prostate cancer	0.000548	0.000834	CcSEcCtD
Tolazamide—Headache—Docetaxel—prostate cancer	0.000544	0.000828	CcSEcCtD
Tolazamide—Asthenia—Prednisone—prostate cancer	0.000537	0.000818	CcSEcCtD
Tolazamide—KCNJ11—Metabolism—HAO1—prostate cancer	0.000532	0.00285	CbGpPWpGaD
Tolazamide—Thrombocytopenia—Doxorubicin—prostate cancer	0.000531	0.000808	CcSEcCtD
Tolazamide—Rash—Capecitabine—prostate cancer	0.00053	0.000807	CcSEcCtD
Tolazamide—Pruritus—Prednisone—prostate cancer	0.00053	0.000807	CcSEcCtD
Tolazamide—Headache—Capecitabine—prostate cancer	0.000527	0.000802	CcSEcCtD
Tolazamide—Nausea—Docetaxel—prostate cancer	0.000516	0.000785	CcSEcCtD
Tolazamide—Dyspepsia—Epirubicin—prostate cancer	0.000516	0.000785	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Epirubicin—prostate cancer	0.000506	0.00077	CcSEcCtD
Tolazamide—Fatigue—Epirubicin—prostate cancer	0.000505	0.000769	CcSEcCtD
Tolazamide—Nausea—Capecitabine—prostate cancer	0.000499	0.00076	CcSEcCtD
Tolazamide—Dizziness—Prednisone—prostate cancer	0.000495	0.000754	CcSEcCtD
Tolazamide—ABCC8—FOXA2 and FOXA3 transcription factor networks—AKT1—prostate cancer	0.000494	0.00265	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000486	0.00261	CbGpPWpGaD
Tolazamide—Feeling abnormal—Epirubicin—prostate cancer	0.000483	0.000735	CcSEcCtD
Tolazamide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—AKT1—prostate cancer	0.000479	0.00257	CbGpPWpGaD
Tolazamide—Dyspepsia—Doxorubicin—prostate cancer	0.000477	0.000726	CcSEcCtD
Tolazamide—Rash—Prednisone—prostate cancer	0.000472	0.000719	CcSEcCtD
Tolazamide—Headache—Prednisone—prostate cancer	0.000469	0.000714	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Doxorubicin—prostate cancer	0.000468	0.000712	CcSEcCtD
Tolazamide—Fatigue—Doxorubicin—prostate cancer	0.000467	0.000711	CcSEcCtD
Tolazamide—Urticaria—Epirubicin—prostate cancer	0.000465	0.000708	CcSEcCtD
Tolazamide—KCNJ1—Neuronal System—MDM2—prostate cancer	0.000455	0.00244	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000449	0.00241	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CBR1—prostate cancer	0.000447	0.0024	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—TST—prostate cancer	0.000447	0.0024	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ADI1—prostate cancer	0.000447	0.0024	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PSAT1—prostate cancer	0.000447	0.0024	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CSAD—prostate cancer	0.000447	0.0024	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GRHL1—prostate cancer	0.000447	0.0024	CbGpPWpGaD
Tolazamide—Feeling abnormal—Doxorubicin—prostate cancer	0.000447	0.00068	CcSEcCtD
Tolazamide—Nausea—Prednisone—prostate cancer	0.000445	0.000677	CcSEcCtD
Tolazamide—ABCC8—Neuronal System—COMT—prostate cancer	0.000435	0.00234	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PSAT1—prostate cancer	0.000433	0.00233	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CSAD—prostate cancer	0.000433	0.00233	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GRHL1—prostate cancer	0.000433	0.00233	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ADI1—prostate cancer	0.000433	0.00233	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—TST—prostate cancer	0.000433	0.00233	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CBR1—prostate cancer	0.000433	0.00233	CbGpPWpGaD
Tolazamide—Urticaria—Doxorubicin—prostate cancer	0.000431	0.000655	CcSEcCtD
Tolazamide—KCNJ11—Neuronal System—COMT—prostate cancer	0.000422	0.00226	CbGpPWpGaD
Tolazamide—Asthenia—Epirubicin—prostate cancer	0.00042	0.00064	CcSEcCtD
Tolazamide—ABCC8—Metabolism—UGT2B17—prostate cancer	0.000416	0.00223	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—UGT2B15—prostate cancer	0.000416	0.00223	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CKMT2—prostate cancer	0.000416	0.00223	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GRHPR—prostate cancer	0.000416	0.00223	CbGpPWpGaD
Tolazamide—Pruritus—Epirubicin—prostate cancer	0.000414	0.000631	CcSEcCtD
Tolazamide—KCNJ11—Metabolism—UGT2B15—prostate cancer	0.000403	0.00216	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CKMT2—prostate cancer	0.000403	0.00216	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—UGT2B17—prostate cancer	0.000403	0.00216	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GRHPR—prostate cancer	0.000403	0.00216	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000396	0.00213	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—NAGLU—prostate cancer	0.000391	0.0021	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—SULT2B1—prostate cancer	0.000391	0.0021	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PGAM2—prostate cancer	0.000391	0.0021	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—MBTPS1—prostate cancer	0.000391	0.0021	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GSTM3—prostate cancer	0.000391	0.0021	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—RFK—prostate cancer	0.000391	0.0021	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—AOX1—prostate cancer	0.000391	0.0021	CbGpPWpGaD
Tolazamide—Asthenia—Doxorubicin—prostate cancer	0.000389	0.000592	CcSEcCtD
Tolazamide—Dizziness—Epirubicin—prostate cancer	0.000387	0.00059	CcSEcCtD
Tolazamide—Pruritus—Doxorubicin—prostate cancer	0.000383	0.000584	CcSEcCtD
Tolazamide—KCNJ11—Metabolism—PGAM2—prostate cancer	0.000379	0.00203	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—MBTPS1—prostate cancer	0.000379	0.00203	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—NAGLU—prostate cancer	0.000379	0.00203	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—SULT2B1—prostate cancer	0.000379	0.00203	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—AOX1—prostate cancer	0.000379	0.00203	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GSTM3—prostate cancer	0.000379	0.00203	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—RFK—prostate cancer	0.000379	0.00203	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000377	0.00202	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CYP3A43—prostate cancer	0.00037	0.00199	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—SRD5A2—prostate cancer	0.00037	0.00199	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—AMACR—prostate cancer	0.00037	0.00199	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—DEGS1—prostate cancer	0.00037	0.00199	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—NAT1—prostate cancer	0.00037	0.00199	CbGpPWpGaD
Tolazamide—Rash—Epirubicin—prostate cancer	0.000369	0.000562	CcSEcCtD
Tolazamide—Headache—Epirubicin—prostate cancer	0.000367	0.000559	CcSEcCtD
Tolazamide—KCNJ11—Metabolism—CYP3A43—prostate cancer	0.000359	0.00193	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—AMACR—prostate cancer	0.000359	0.00193	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—DEGS1—prostate cancer	0.000359	0.00193	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—NAT1—prostate cancer	0.000359	0.00193	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—SRD5A2—prostate cancer	0.000359	0.00193	CbGpPWpGaD
Tolazamide—Dizziness—Doxorubicin—prostate cancer	0.000358	0.000546	CcSEcCtD
Tolazamide—ABCC8—Metabolism—HSD17B1—prostate cancer	0.000353	0.0019	CbGpPWpGaD
Tolazamide—Nausea—Epirubicin—prostate cancer	0.000348	0.00053	CcSEcCtD
Tolazamide—KCNJ11—Metabolism—HSD17B1—prostate cancer	0.000343	0.00184	CbGpPWpGaD
Tolazamide—Rash—Doxorubicin—prostate cancer	0.000342	0.00052	CcSEcCtD
Tolazamide—Headache—Doxorubicin—prostate cancer	0.00034	0.000517	CcSEcCtD
Tolazamide—Nausea—Doxorubicin—prostate cancer	0.000322	0.00049	CcSEcCtD
Tolazamide—ABCC8—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.000321	0.00172	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—HPGD—prostate cancer	0.000315	0.00169	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—B4GALT4—prostate cancer	0.000315	0.00169	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—HPGD—prostate cancer	0.000305	0.00164	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—B4GALT4—prostate cancer	0.000305	0.00164	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.000303	0.00163	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—TNFRSF21—prostate cancer	0.000296	0.00159	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.000289	0.00155	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—MTAP—prostate cancer	0.000288	0.00155	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CYP7B1—prostate cancer	0.000288	0.00155	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—TNFRSF21—prostate cancer	0.000287	0.00154	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—SRD5A1—prostate cancer	0.000281	0.00151	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—SULT1E1—prostate cancer	0.000281	0.00151	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—MTAP—prostate cancer	0.000279	0.0015	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CYP7B1—prostate cancer	0.000279	0.0015	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—SULT1E1—prostate cancer	0.000272	0.00146	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—SRD5A1—prostate cancer	0.000272	0.00146	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—HSD17B3—prostate cancer	0.000268	0.00144	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ACSL4—prostate cancer	0.000268	0.00144	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—HSD17B3—prostate cancer	0.00026	0.00139	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ACSL4—prostate cancer	0.00026	0.00139	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PHGDH—prostate cancer	0.000257	0.00138	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—UMPS—prostate cancer	0.000257	0.00138	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ARG2—prostate cancer	0.000257	0.00138	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.000255	0.00137	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—LDHB—prostate cancer	0.000252	0.00135	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ARG2—prostate cancer	0.000249	0.00134	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—UMPS—prostate cancer	0.000249	0.00134	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PHGDH—prostate cancer	0.000249	0.00134	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CYP3A5—prostate cancer	0.000247	0.00133	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—LDHB—prostate cancer	0.000244	0.00131	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—RXRA—prostate cancer	0.000243	0.0013	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CYP3A5—prostate cancer	0.00024	0.00129	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PDHA1—prostate cancer	0.000239	0.00128	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—TCN2—prostate cancer	0.000239	0.00128	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GSTA3—prostate cancer	0.000239	0.00128	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—UCP3—prostate cancer	0.000239	0.00128	CbGpPWpGaD
Tolazamide—ABCC8—Neuronal System—MDM2—prostate cancer	0.000233	0.00125	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PDHA1—prostate cancer	0.000231	0.00124	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—UCP3—prostate cancer	0.000231	0.00124	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GSTA3—prostate cancer	0.000231	0.00124	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—TCN2—prostate cancer	0.000231	0.00124	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—HSD3B1—prostate cancer	0.000228	0.00122	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—SLC22A3—prostate cancer	0.000228	0.00122	CbGpPWpGaD
Tolazamide—KCNJ11—Neuronal System—MDM2—prostate cancer	0.000226	0.00121	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—SLC22A3—prostate cancer	0.000221	0.00118	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—HSD3B1—prostate cancer	0.000221	0.00118	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—TBXAS1—prostate cancer	0.000218	0.00117	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GSTA4—prostate cancer	0.000218	0.00117	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GSTA2—prostate cancer	0.000213	0.00114	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GSTA4—prostate cancer	0.000212	0.00114	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—TBXAS1—prostate cancer	0.000212	0.00114	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—SULT1A1—prostate cancer	0.00021	0.00113	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ABCG5—prostate cancer	0.00021	0.00113	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GSTA2—prostate cancer	0.000206	0.00111	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GSTA1—prostate cancer	0.000205	0.0011	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—SULT1A1—prostate cancer	0.000204	0.00109	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ABCG5—prostate cancer	0.000204	0.00109	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—HSD3B2—prostate cancer	0.000203	0.00109	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GSTO1—prostate cancer	0.000203	0.00109	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—NAT2—prostate cancer	0.000203	0.00109	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GSTA1—prostate cancer	0.000199	0.00107	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GSTO1—prostate cancer	0.000197	0.00106	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—HSD3B2—prostate cancer	0.000197	0.00106	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—NAT2—prostate cancer	0.000197	0.00106	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PLCB2—prostate cancer	0.000195	0.00104	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CYP2C18—prostate cancer	0.000195	0.00104	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—LRP2—prostate cancer	0.000195	0.00104	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—P4HB—prostate cancer	0.000191	0.00102	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PLCB2—prostate cancer	0.000189	0.00101	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CYP2C18—prostate cancer	0.000189	0.00101	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—LRP2—prostate cancer	0.000189	0.00101	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—SLC22A1—prostate cancer	0.000186	0.000996	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—PPARA—prostate cancer	0.000186	0.000996	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—P4HB—prostate cancer	0.000185	0.000993	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—SULT2A1—prostate cancer	0.000181	0.000971	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—SLC22A1—prostate cancer	0.00018	0.000966	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—MED12—prostate cancer	0.000178	0.000955	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GNG5—prostate cancer	0.000177	0.000947	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—SULT2A1—prostate cancer	0.000175	0.000941	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—MED12—prostate cancer	0.000173	0.000926	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GNG5—prostate cancer	0.000171	0.000919	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—NCOA3—prostate cancer	0.00017	0.000913	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—NCOA3—prostate cancer	0.000165	0.000885	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—HPGDS—prostate cancer	0.000162	0.000871	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CYP2C19—prostate cancer	0.000161	0.000865	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ACHE—prostate cancer	0.000157	0.000844	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GSTT1—prostate cancer	0.000157	0.000844	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—HPGDS—prostate cancer	0.000157	0.000844	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CYP2C19—prostate cancer	0.000156	0.000839	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CYP2A6—prostate cancer	0.000156	0.000835	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GSTT1—prostate cancer	0.000153	0.000819	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ACHE—prostate cancer	0.000153	0.000819	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—AKR1C3—prostate cancer	0.000151	0.000812	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CYP2A6—prostate cancer	0.000151	0.000809	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PRKACB—prostate cancer	0.00015	0.000808	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CYP17A1—prostate cancer	0.000149	0.000799	CbGpPWpGaD
Tolazamide—ABCC8—Transmembrane transport of small molecules—CREBBP—prostate cancer	0.000147	0.000791	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—AKR1C3—prostate cancer	0.000147	0.000787	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PRKACB—prostate cancer	0.000146	0.000783	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CYP17A1—prostate cancer	0.000144	0.000775	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—NCOA2—prostate cancer	0.000142	0.000762	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—NCOA2—prostate cancer	0.000138	0.000739	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—SLC5A5—prostate cancer	0.000135	0.000727	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CYP2E1—prostate cancer	0.000132	0.00071	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—SLC5A5—prostate cancer	0.000131	0.000705	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—NQO1—prostate cancer	0.000131	0.000702	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—TH—prostate cancer	0.000129	0.000692	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CYP2E1—prostate cancer	0.000128	0.000688	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CYP3A4—prostate cancer	0.000128	0.000684	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—NQO1—prostate cancer	0.000127	0.00068	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CYP1B1—prostate cancer	0.000125	0.000673	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—TH—prostate cancer	0.000125	0.000671	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CYP3A4—prostate cancer	0.000124	0.000664	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CYP1B1—prostate cancer	0.000122	0.000652	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GGT1—prostate cancer	0.000121	0.000652	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—NCOA1—prostate cancer	0.00012	0.000642	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CYP19A1—prostate cancer	0.000118	0.000633	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GGT1—prostate cancer	0.000118	0.000632	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—NCOA1—prostate cancer	0.000116	0.000622	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CYP19A1—prostate cancer	0.000114	0.000613	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—RXRA—prostate cancer	0.000114	0.00061	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—RXRA—prostate cancer	0.00011	0.000592	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—COMT—prostate cancer	0.00011	0.000588	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GSTP1—prostate cancer	0.000109	0.000585	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ITPR1—prostate cancer	0.000107	0.000576	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—COMT—prostate cancer	0.000106	0.00057	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GSTP1—prostate cancer	0.000106	0.000568	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ITPR1—prostate cancer	0.000104	0.000558	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—TYMS—prostate cancer	0.000101	0.000544	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—GSTM1—prostate cancer	0.0001	0.000538	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—LPL—prostate cancer	9.84e-05	0.000528	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—TYMS—prostate cancer	9.83e-05	0.000528	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—GSTM1—prostate cancer	9.72e-05	0.000522	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—LPL—prostate cancer	9.54e-05	0.000512	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CYP1A1—prostate cancer	9.5e-05	0.00051	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—ERCC2—prostate cancer	9.42e-05	0.000506	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CYP1A1—prostate cancer	9.21e-05	0.000494	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—ERCC2—prostate cancer	9.14e-05	0.00049	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—MTHFR—prostate cancer	8.86e-05	0.000475	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PPARA—prostate cancer	8.69e-05	0.000466	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—MTHFR—prostate cancer	8.59e-05	0.000461	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PPARA—prostate cancer	8.43e-05	0.000452	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CAV1—prostate cancer	8.17e-05	0.000438	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CAV1—prostate cancer	7.92e-05	0.000425	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PIK3CG—prostate cancer	7.44e-05	0.000399	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PIK3CG—prostate cancer	7.22e-05	0.000387	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—INS—prostate cancer	7.04e-05	0.000378	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CREBBP—prostate cancer	6.9e-05	0.00037	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—INS—prostate cancer	6.83e-05	0.000367	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CREBBP—prostate cancer	6.69e-05	0.000359	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PIK3CD—prostate cancer	6.54e-05	0.000351	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PIK3CD—prostate cancer	6.34e-05	0.00034	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—NOS3—prostate cancer	6.18e-05	0.000332	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—NOS3—prostate cancer	5.99e-05	0.000321	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PIK3CB—prostate cancer	5.7e-05	0.000306	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PTGS2—prostate cancer	5.65e-05	0.000303	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PIK3CB—prostate cancer	5.53e-05	0.000297	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PTGS2—prostate cancer	5.48e-05	0.000294	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PTEN—prostate cancer	4.93e-05	0.000264	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PTEN—prostate cancer	4.78e-05	0.000256	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—EP300—prostate cancer	4.7e-05	0.000252	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—EP300—prostate cancer	4.56e-05	0.000245	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PIK3CA—prostate cancer	3.48e-05	0.000187	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PIK3CA—prostate cancer	3.37e-05	0.000181	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—AKT1—prostate cancer	2.84e-05	0.000152	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—AKT1—prostate cancer	2.75e-05	0.000148	CbGpPWpGaD
